Open Access

Retraction Note: Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients

  • Ali Arabkheradmand1,
  • Aghdas Safari2,
  • Mehri Seifoleslami2,
  • Emad Yahaghi3 and
  • Masoumeh Gity4Email author
Diagnostic Pathology201611:122

https://doi.org/10.1186/s13000-016-0560-9

Received: 17 October 2016

Accepted: 19 October 2016

Published: 2 November 2016

The original article was published in Diagnostic Pathology 2015 10:178

Retraction

The Editor-in-Chief and Publisher have retracted this article [1] because the scientific integrity of the content cannot be guaranteed. An investigation by the Publisher found it to be one of a group of articles we have identified as showing evidence suggestive of attempts to subvert the peer review and publication system to inappropriately obtain or allocate authorship. This article showed evidence of plagiarism (most notably from the articles cited [24]) and authorship manipulation.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Surgery, Cancer and Reconstructive Surgeon, Cancer Institute, School of Medicine, Tehran University of Medical Sciences
(2)
Department of Gynecology, Khanevadeh Hospital, AJA University of Medical Sciences
(3)
Department of Molecular Biology, Baqiyatallah University of Medical Sciences
(4)
Department of Radiology, Medical Imaging Center, Tehran University of Medical Sciences

References

  1. Arabkheradmand A, Safari A, Seifoleslami M, Yahaghi E, Gity M. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients. Diagn Pathol. 2015;10:178.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Li L, Luo J, Wang B, Wang D, Xie X, Yuan L, Guo J, Xi S, Gao J, Lin X, Kong Y, Xu X, Tang H, Xie X, Liu M. Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer. Mol Cancer. 2013;12:163.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Chang H, Zhou X, Wang Z-N, Song Y-X, Zhao F, Gao P, Chiang Y, Xu H-M. Increased expression of miR-148b in ovarian carcinoma and its clinical significance. Mol Med Rep. 2012;5(5):1277–80.PubMedGoogle Scholar
  4. Yu S-L, Chen H-Y, Chang G-C, Chen C-Y, Chen H-W, Singh S, Cheng C-L, Yu C-J, Lee Y-C, Chen H-S, Su T-J, Chiang C-C, Li H-N, Hong Q-S, Su H-Y, Chen C-C, Chen W-J, Liu C-C, Chan W-K, Chen WJ, Li K-C, Chen JJW, Yang P-C. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell. 2008;13(1):48–57.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement